Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000950170-25-043975

Chief Executive Officer sold 10,031 shares at $41.23 ($413,578)

  • Chief Executive Officer acquired 19,688 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2025-03-20 Option exercise +19,688 205,116 D
Kulkarni Samarth Chief Executive Officer 2025-03-21 Sale −10,031 $41.23 $413,578 195,085 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2025-03-20 Option exercise · Restricted Stock Units −19,688 59,062 D
Open-market sales · 10,031 sh · avg $41.23 · $413,578
Loading xslF345X05/ownership.xml…